Adar1 Capital Management, LLC 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Adar1 Capital Management, LLC disclosed 293 US equity positions worth $1.7bn in its Q1 2026 13F filing. The largest position was ABVX at 9.3% of the reported book, followed by PTGX and ROIV.
What did Adar1 Capital Management, LLC own in Q1 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | ABVX ABIVAX SA | Healthcare | 9.3% | $155.2m | 1,394,019 | – | |
| 2 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 6.3% | $104.8m | 994,119 | – | |
| 3 | ROIV ROIVANT SCIENCES LTD | Healthcare | 5.5% | $91.0m | 3,285,906 | – | |
| 4 | IMVT IMMUNOVANT INC | Healthcare | 4.0% | $66.5m | 2,679,010 | – | |
| 5 | SPY STATE STR SPDR S&P 500 ETF T | 3.0% | $49.4m | 75,940 | – | ||
| 6 | 430 TERNS PHARMACEUTICALS INC | 2.9% | $48.2m | 914,699 | – | ||
| 7 | CYTK CYTOKINETICS INC | Healthcare | 2.5% | $41.7m | 632,556 | – | |
| 8 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 2.5% | $41.4m | 1,139,331 | – | ||
| 9 | BOXX EA SERIES TRUST | 2.4% | $39.2m | 337,125 | – | ||
| 10 | DNLI DENALI THERAPEUTICS INC | Healthcare | 2.2% | $35.9m | 1,871,455 | – | |
| 11 | BEAM BEAM THERAPEUTICS INC | Healthcare | 2.1% | $34.5m | 1,446,375 | – | |
| 12 | ZLAB ZAI LAB LTD | Healthcare | 1.6% | $26.8m | 1,425,367 | – | |
| 13 | SEPN SEPTERNA INC | Healthcare | 1.6% | $26.2m | 1,089,818 | – | |
| 14 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 1.5% | $24.6m | 2,744,714 | – | |
| 15 | DBVT DBV TECHNOLOGIES S A | 1.3% | $21.2m | 1,012,866 | – | ||
| 16 | AVR ANTERIS TECHNOLOGIES GLOBAL | 1.3% | $21.0m | 3,789,132 | – | ||
| 17 | INSP INSPIRE MED SYS INC | Healthcare | 1.3% | $20.9m | 405,197 | – | |
| 18 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 1.2% | $20.0m | 407,273 | – | |
| 19 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 1.1% | $18.4m | 211,450 | – | |
| 20 | SYRE SPYRE THERAPEUTICS INC | Healthcare | 1.0% | $17.1m | 338,323 | – | |
| 21 | CTMX CYTOMX THERAPEUTICS INC. | Healthcare | 1.0% | $16.0m | 3,410,190 | – | |
| 22 | PRTA PROTHENA CORP PLC | Healthcare | 0.9% | $15.4m | 1,581,443 | – | |
| 23 | SNY SANOFI SA | Healthcare | 0.9% | $15.3m | 316,939 | – | |
| 24 | PCVX VAXCYTE INC | Healthcare | 0.9% | $15.1m | 259,137 | – | |
| 25 | MNPR MONOPAR THERAPEUTICS INC | 0.9% | $14.5m | 264,278 | – | ||
| 26 | ABUS ARBUTUS BIOPHARMA CORP | Healthcare | 0.8% | $14.1m | 3,133,175 | – | |
| 27 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 0.8% | $13.9m | 1,000,604 | – | |
| 28 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 0.8% | $13.6m | 427,816 | – | |
| 29 | TSHA TAYSHA GENE THERAPIES INC | Healthcare | 0.8% | $13.3m | 2,979,429 | – | |
| 30 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.8% | $13.3m | 228,899 | – | |
| 31 | STRO SUTRO BIOPHARMA INC | Healthcare | 0.8% | $13.1m | 524,441 | – | |
| 32 | RVMD REVOLUTION MEDICINES INC | Healthcare | 0.8% | $13.0m | 133,893 | – | |
| 33 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 0.8% | $12.9m | 329,540 | – | |
| 34 | CGON CG ONCOLOGY INC | Healthcare | 0.8% | $12.6m | 185,699 | – | |
| 35 | BIL SPDR SERIES TRUST | 0.7% | $12.4m | 135,585 | – | ||
| 36 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 0.7% | $12.1m | 213,473 | – | |
| 37 | REPL REPLIMUNE GROUP INC | Healthcare | 0.7% | $12.1m | 1,582,987 | – | |
| 38 | IVA INVENTIVA SA | 0.7% | $12.1m | 2,174,398 | – | ||
| 39 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 0.7% | $12.0m | 160,338 | – | |
| 40 | NKTR NEKTAR THERAPEUTICS | Healthcare | 0.7% | $11.6m | 161,252 | – | |
| 41 | IKT INHIBIKASE THERAPEUTICS INC | 0.7% | $11.1m | 6,606,572 | – | ||
| 42 | SPRY ARS PHARMACEUTICALS INC | Healthcare | 0.7% | $10.9m | 1,361,536 | – | |
| 43 | HELIX ACQUISITION CORP III | 0.6% | $10.3m | 1,000,000 | – | ||
| 44 | OVID OVID THERAPEUTICS INC | Healthcare | 0.6% | $10.1m | 4,544,113 | – | |
| 45 | OKUR ONKURE THERAPEUTICS INC | 0.6% | $10.1m | 2,434,941 | – | ||
| 46 | REGN REGENERON PHARMACEUTICALS | Healthcare | 0.6% | $9.4m | 12,154 | – | |
| 47 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 0.5% | $8.5m | 457,137 | – | |
| 48 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 0.5% | $8.4m | 1,467,350 | – | |
| 49 | IRD OPUS GENETICS INC | 0.5% | $8.4m | 1,849,004 | – | ||
| 50 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 0.5% | $8.1m | 268,391 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.